Tackling the Last Mile: A Major Component to Successfully Establish Radioligand Therapy

Kelsey L. Pomykala; Marcus Würker; Ken Herrmann

doi:10.2967/jnumed.122.264900

Research ArticleHot Topics

Tackling the Last Mile: A Major Component to Successfully Establish Radioligand Therapy

Kelsey L. Pomykala, Marcus Würker and Ken Herrmann

Journal of Nuclear Medicine March 2023, 64 (3) 347-348; DOI: https://doi.org/10.2967/jnumed.122.264900

Kelsey L. Pomykala

1Institute for Artificial Intelligence in Medicine, University Hospital Essen, Essen, Germany;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Marcus Würker

2Deutsche Post DHL Group, Bonn, Germany; and

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Ken Herrmann

3Department of Nuclear Medicine, University of Duisburg–Essen, and German Cancer Consortium–University Hospital Essen, Essen, Germany

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Info & Metrics
PDF

Article Information

vol. 64 no. 3 347-348

DOI

https://doi.org/10.2967/jnumed.122.264900

PubMed

36549917

Published By

Society of Nuclear Medicine

Print ISSN

0161-5505

Online ISSN

2159-662X

History

Received for publication October 13, 2022
Revision received December 21, 2022
Published online March 2, 2023.

Article Versions

previous version (December 22, 2022 - 11:24).
You are viewing the most recent version of this article.

Author Information

Statistics from Altmetric.com

Cited By...

1 Citations
4 Citations
Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

Radiotheranostics Global Market and Future Developments

Akram Al-Ibraheem, Richard Zimmermann, Ahmed S. Abdlkadir, Ken Herrmann

Seminars in Nuclear Medicine 2024 54 4
Synthesis of 177Lu-Labeled, Somatostatin-2 Receptor-Targeted Metalla-Assemblies: Challenges in the Design of Supramolecular Radiotherapeutics

Sandra Deiser, Marike Drexler, Guillermo Moreno-Alcántar, Maximilian Irl, Claudia Schmidt, Thomas Günther, Angela Casini

Inorganic Chemistry 2023 62 50
The177Lu-PSMA-617 (Pluvicto) Supply Problem Will Be Solved by Competition

Johannes Czernin, Jeremie Calais

Journal of Nuclear Medicine 2023 64 3
Differences and Common Ground in177Lu-PSMA Radioligand Therapy Practice Patterns: International Survey of 95 Theranostic Centers

Andrea Farolfi, Wesley R. Armstrong, Loic Djaileb, Andrei Gafita, Masatoshi Hotta, Martin Allen-Auerbach, Lena M. Unterrainer, Wolfgang P. Fendler, Matthew Rettig, Matthias Eiber, Michael S. Hofman, Boris Hadaschik, Ken Herrmann, Johannes Czernin, Jeremie Calais, Matthias R. Benz

Journal of Nuclear Medicine 2024 65 3

Article usage

Article usage: December 2022 to September 2024

	Full	Pdf
Dec 2022	0	44
Jan 2023	0	109
Feb 2023	0	17
Mar 2023	268	116
Apr 2023	368	54
May 2023	256	44
Jun 2023	245	64
Jul 2023	270	32
Aug 2023	334	58
Sep 2023	232	38
Oct 2023	132	39
Nov 2023	121	41
Dec 2023	64	35
Jan 2024	217	44
Feb 2024	222	32
Mar 2024	148	60
Apr 2024	67	23
May 2024	70	29
Jun 2024	126	44
Jul 2024	164	48
Aug 2024	155	50
Sep 2024	85	33

PreviousNext

In this issue

Journal of Nuclear Medicine

Vol. 64, Issue 3

March 1, 2023

Table of Contents
Table of Contents (PDF)
About the Cover
Index by author
Complete Issue (PDF)

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Tackling the Last Mile: A Major Component to Successfully Establish Radioligand Therapy

Message Subject (Your Name) has sent you a message from Journal of Nuclear Medicine

Message Body (Your Name) thought you would like to see the Journal of Nuclear Medicine web site.

Your Personal Message

Citation Tools

Tackling the Last Mile: A Major Component to Successfully Establish Radioligand Therapy

Kelsey L. Pomykala, Marcus Würker, Ken Herrmann

Journal of Nuclear Medicine Mar 2023, 64 (3) 347-348; DOI: 10.2967/jnumed.122.264900

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Tackling the Last Mile: A Major Component to Successfully Establish Radioligand Therapy

Kelsey L. Pomykala, Marcus Würker, Ken Herrmann

Journal of Nuclear Medicine Mar 2023, 64 (3) 347-348; DOI: 10.2967/jnumed.122.264900

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Bookmark this article

User Name *

Password *

Remember my user name & password.

Jump to section

Article
Info & Metrics
PDF

No related articles found.

PubMed
Google Scholar

Cited By...

Differences and Common Ground in 177Lu-PSMA Radioligand Therapy Practice Patterns: International Survey of 95 Theranostic Centers
The 177Lu-PSMA-617 (Pluvicto) Supply Problem Will Be Solved by Competition

Google Scholar

Main menu

User menu

Search

Tackling the Last Mile: A Major Component to Successfully Establish Radioligand Therapy

Article Information

Article Versions

Author Information

Statistics from Altmetric.com

Cited By...

Article usage

Article usage: December 2022 to September 2024

In this issue

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Similar Articles